Biomarker Statistics

Innovative and customized.

Biomarkers are becoming an essential part of drug discovery and developmental processes in pharmaceutical research. They serve as diagnostic tools for patient selection, surrogate endpoints in clinical trials or development of personalized therapies. Modern technology, high-dimensional data and specific issues present challenges in the statistical analysis of biomarker data.

Chrestos supports you in the planning of the trial to the statistical analysis to the interpretation and communication of the results.

Our biomarker statisticians give you advise on the design and work together with you in developing a suitable statistical analysis plan.
After professional data development and quality control, we program and validate the statistical analyses using the software R or SAS. In addition, we develop tailor-made R-Shiny Web applications for an interactive analysis of your data.

Our team creates high-quality result reports, data visualizations and presentations. Moreover, we support you in communicating and presenting the results in interdisciplinary teams and in drawing up scientific publications.

You can benefit from our profound biostatistical and bioinformatic expertise in standardized- and individual analyses. Our biomarker statisticians are experienced in pre-clinical studies, clinical studies from phases I to III and non-clinical studies. Our team is familiar with a lot of different measuring technologies (among other things RT-qPCR, RNAseq, gene expression arrays) and quarantees up to date performance through expert training.

CRO overview

Discover the world of Contract Research Organization.

Not only performance and service are just right, but above all the quality.

Please contact us, we would be delighted to give you some personal advice.